Tag: CRISPR

New sickle cell treatment has roots at Children’s Hospital of Philadelphia
Health

New sickle cell treatment has roots at Children’s Hospital of Philadelphia

Sickle cell therapy pioneered at CHOP a "real gamechanger" Sickle cell therapy pioneered at CHOP a "real gamechanger" 02:40 PHILADELPHIA (CBS) – A new medical breakthrough has roots in Philadelphia. The Food and Drug Administration recently approved the first gene therapies to treat patients with sickle cell disease, an inherited blood disorder that strikes mainly people of color. "You feel like somebody is taking a sledgehammer to your bones and hitting it over and over again," said...
New sickle cell treatment has roots at Children’s Hospital of Philadelphia
Health

New sickle cell treatment has roots at Children’s Hospital of Philadelphia

PHILADELPHIA (CBS) – A new medical breakthrough has roots in Philadelphia. The Food and Drug Administration recently approved the first gene therapies to treat patients with sickle cell disease, an inherited blood disorder that strikes mainly people of color. "You feel like somebody is taking a sledgehammer to your bones and hitting it over and over again," said Daniels Tornyenu, who has sickle cell disease. His daughter, Marie-Chantal Tornyenu, has the illness as well. "In my chest, it's like this hollow burning almost, and then I can't breathe on top of it," Marie-Chantal Tornyenu said. RELATED: FDA approves gene-editing treatment for sickle cell diseasePain from sickle cell can happen anywhere blood circulates. Because red blood cells, which are normally round, bend into inflexible s...
Jennifer Doudna Believes Crispr Is for Everyone
Technology

Jennifer Doudna Believes Crispr Is for Everyone

It’s been a monumental year for Crispr, the molecular tool scientists use to edit genetic material. This November, the United Kingdom authorized the first medical treatment using Crispr gene editing, giving people with sickle cell disease new opportunities to receive a one-time therapy to prevent episodes of terrible pain. This week, the US Food and Drug Administration is poised to make a decision about the therapy. What was once seen as a moonshot is already changing lives.Right now, though, it’s still a rarefied treatment. “It’s expensive,” Jennifer Doudna, the pioneering biochemist who won a Nobel Prize in 2020 for her work on Crispr, told WIRED’s Emily Mullin at the LiveWIRED conference this week in San Francisco. The therapy is expected to be priced at over a million dollars a patien...
World’s first gene therapy for sickle cell and thalassemia approved in the U.K.
Health

World’s first gene therapy for sickle cell and thalassemia approved in the U.K.

Expert joins CBS New York to discuss new sickle cell treatment Expert joins CBS New York to discuss new sickle cell treatment 02:46 Britain's medicines regulator has authorized the world's first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K.In a statement on Thursday, the Medicines and Healthcare Regulatory Agency said it approved Casgevy, the first medicine licensed using the gene editing ...